AKT1 and gastric cancer: Intriguingly, using PI3K/Akt pathway inhibitors in gastric cancer cell lines caused cell cycle arrest, enhanced sensitivity to apoptosis and attenuated the chemotherapeutic resistance of GC cells [91–94].